SCHEMBL26548536

SCHEMBL26548536

Cc1nccn1-c1ccc(NC(C)C)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PCSK9 Q8NBP7 1/20 0.54
CYP3A4 P08684 3/20 0.51
CYP2E1 P05181 1/20 0.51
CYP2A6 P11509 1/20 0.51
ALDH1A1 P00352 1/20 0.45
CYP2D6 P10635 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HCAR3 P49019 1/20 0.42
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
ADH5 P11766 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26551517 0.79 HRH4 (0.47) PCSK9CYP3A4CYP2E1CYP2A6ALDH1A1
SCHEMBL30558759 0.74 ALDH1A1 (0.71) CYP3A4CYP2E1CYP2A6ALDH1A1CYP2D6
SCHEMBL26547633 0.73 PCSK9 (0.54) PCSK9CYP3A4CYP2A6CYP2D6CYP1A2
SCHEMBL27585155 0.72 CYP3A4 (0.59) PCSK9CYP3A4CYP2E1CYP2A6ALDH1A1
SCHEMBL26550116 0.71 CDK6 (0.46) PCSK9CYP3A4ALDH1A1CYP1A2CYP2C9
SCHEMBL22241693 0.71 PCSK9 (1.00) PCSK9
SCHEMBL10022328 0.70 ALDH1A1 (0.57) PCSK9CYP3A4CYP2E1CYP2A6ALDH1A1
SCHEMBL6921057 0.69 HCAR3 (0.55) ALDH1A1HCAR3GAA
SCHEMBL30305324 0.69 ADH5 (0.66) CYP3A4CYP2E1CYP2A6ALDH1A1CYP2D6
SCHEMBL8268417 0.69 ALDH1A1 (0.65) CYP3A4CYP2E1CYP2A6ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed